Search Results - "Paolo, Therese Di"

Refine Results
  1. 1

    Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research by Litim, Nadhir, Morissette, Marc, Di Paolo, Thérèse

    Published in Neuropharmacology (15-03-2017)
    “…Disturbance of glutamate neurotransmission in Parkinson's disease (PD) and l-DOPA induced dyskinesia (LID) is well documented. This review focuses on advances…”
    Get full text
    Journal Article
  2. 2

    Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice by Bourque, Mélanie, Morissette, Marc, Di Paolo, Thérèse

    Published in Neurobiology of aging (01-10-2014)
    “…Abstract Raloxifene, used in the clinic, is reported to protect brain dopaminergic neurons in mice. Raloxifene was shown to mediate an effect through the G…”
    Get full text
    Journal Article
  3. 3

    Neuroprotective actions of sex steroids in Parkinson’s disease by Bourque, Mélanie, Dluzen, Dean E, Di Paolo, Thérèse

    Published in Frontiers in neuroendocrinology (01-07-2009)
    “…Abstract The sex difference in Parkinson’s disease, with a higher susceptibility in men, suggests a modulatory effect of sex steroids in the brain. Numerous…”
    Get full text
    Journal Article
  4. 4

    Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments by Di Paolo, Thérèse, Morin, Nicolas, Côté, Mélissa, Aubé, Benoit, Poirier, Andrée-Anne, Soulet, Denis

    Published in Parkinson's disease (01-01-2016)
    “…A diagnosis of Parkinson’s disease is classically established after the manifestation of motor symptoms such as rigidity, bradykinesia, and tremor. However, a…”
    Get full text
    Journal Article
  5. 5

    Neuroprotective and immunomodulatory effects of raloxifene in the myenteric Plexus of a mouse model of Parkinson’s disease by Poirier, Andrée-Anne, Côté, Mélissa, Bourque, Mélanie, Morissette, Marc, Di Paolo, Thérèse, Soulet, Denis

    Published in Neurobiology of aging (01-12-2016)
    “…Abstract Motor symptoms in Parkinson’s disease (PD) are often preceded by non-motor symptoms related to dysfunctions of the autonomic nervous system such as…”
    Get full text
    Journal Article
  6. 6

    Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease by Jarras, Hend, Bourque, Mélanie, Poirier, Andrée‐Anne, Morissette, Marc, Coulombe, Katherine, Di Paolo, Thérèse, Soulet, Denis

    Published in Journal of neuroendocrinology (01-01-2020)
    “…Gastrointestinal symptoms appear in Parkinson's disease patients many years before motor symptoms, suggesting the implication of dopaminergic neurones of the…”
    Get full text
    Journal Article
  7. 7

    Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice by Miville-Godbout, Edith, Bourque, Mélanie, Morissette, Marc, Al-Sweidi, Sara, Smith, Tara, Mochizuki, Asuka, Senanayake, Vijitha, Jayasinghe, Dushmanthi, Wang, Li, Goodenowe, Dayan, Di Paolo, Thérèse

    Published in PloS one (09-03-2016)
    “…Plasmalogens are a class of glycerophospholipids shown to play critical roles in membrane structure and function. Decreased plasmalogens are reported in the…”
    Get full text
    Journal Article
  8. 8

    The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys by Petryszyn, Sarah, Di Paolo, Thérèse, Parent, André, Parent, Martin

    Published in Neurobiology of disease (01-11-2016)
    “…Abstract The most abundant interneurons in the primate striatum are those expressing the calcium-binding protein calretinin (CR). The present…”
    Get full text
    Journal Article
  9. 9

    Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson's Disease by Isenbrandt, Amandine, Coulombe, Katherine, Morissette, Marc, Bourque, Mélanie, Lamontagne-Proulx, Jérôme, Di Paolo, Thérèse, Soulet, Denis

    Published in Pharmaceuticals (Basel, Switzerland) (20-01-2023)
    “…Parkinson's disease (PD) is characterized by neurodegeneration and neuroinflammation. PD prevalence and incidence are higher in men than in women and…”
    Get full text
    Journal Article
  10. 10

    Sex and Age Differences in a Progressive Synucleinopathy Mouse Model by Lamontagne-Proulx, Jérôme, Coulombe, Katherine, Morissette, Marc, Rieux, Marie, Calon, Frédéric, Di Paolo, Thérèse, Soulet, Denis

    Published in Biomolecules (Basel, Switzerland) (01-06-2023)
    “…The mutation and overexpression of the alpha-synuclein protein (αSyn), described as synucleinopathy, is associated with Parkinson's disease (PD)-like…”
    Get full text
    Journal Article
  11. 11

    GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease by Côté, Mélissa, Bourque, Mélanie, Poirier, Andrée-Anne, Aubé, Benoit, Morissette, Marc, Di Paolo, Thérèse, Soulet, Denis

    Published in Neurobiology of disease (01-10-2015)
    “…Abstract Lewy pathology affects the gastrointestinal tract in Parkinson's disease (PD) and recent reports suggest a link between the disorder and gut…”
    Get full text
    Journal Article
  12. 12

    Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease by Bourque, Mélanie, Morissette, Marc, Côté, Mélissa, Soulet, Denis, Di Paolo, Thérèse

    Published in Neurobiology of aging (01-03-2013)
    “…Abstract This study investigated the contribution of the new G protein-coupled estrogen receptor 1 (GPER1) in neuroprotection by 17β-estradiol in the…”
    Get full text
    Journal Article
  13. 13

    Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys by Gagnon, Dave, Eid, Lara, Coudé, Dymka, Whissel, Carl, Di Paolo, Thérèse, Parent, André, Parent, Martin

    Published in Frontiers in neuroanatomy (15-05-2018)
    “…This light and electron microscopie immunohistochemical quantitative study aimed at determining the state of the dopamine (DA) and serotonin (5-HT)…”
    Get full text
    Journal Article
  14. 14

    Steroids‐Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders by Sánchez, Maria Gabriela, Bourque, Mélanie, Morissette, Marc, Di Paolo, Thérèse

    Published in CNS neuroscience & therapeutics (01-06-2010)
    “…SUMMARY Introduction: Dopamine cell loss is well documented in Parkinson's disease and dopamine hypofunction is proposed in certain depressive states. At the…”
    Get full text
    Journal Article
  15. 15

    Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice by Bourque, Mélanie, Morissette, Marc, Al Sweidi, Sara, Caruso, Donatella, Melcangi, Roberto C, Di Paolo, Thérèse

    Published in Neuroendocrinology (01-01-2016)
    “…Numerous studies have reported on the neuroprotective activity of estradiol, whereas the effect of the other ovarian steroid, progesterone, is much less…”
    Get more information
    Journal Article
  16. 16

    Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys by Morin, Nicolas, Jourdain, Vincent A., Morissette, Marc, Grégoire, Laurent, Di Paolo, Thérèse

    Published in Neuropharmacology (01-04-2014)
    “…Brain glutamate overactivity is well documented in Parkinson's disease (PD) and antiglutamatergic drugs decrease L-3,4-dihydroxyphenylalanine (l-DOPA)-induced…”
    Get full text
    Journal Article
  17. 17

    Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson's Disease Models by Poirier, Andrée-Anne, Côté, Mélissa, Jarras, Hend, Litim, Nadhir, Lamontagne-Proulx, Jérôme, Al-Sweidi, Sara, Morissette, Marc, Lachhab, Asmaa, Pelletier, Martin, Di Paolo, Thérèse, Soulet, Denis

    Published in Frontiers in pharmacology (22-07-2022)
    “…Gastrointestinal disorders in Parkinson's disease (PD) have been associated with neuronal alteration in the plexus of the gut. We previously demonstrated the…”
    Get full text
    Journal Article
  18. 18

    Metabotropic Glutamate Receptors for Parkinson's Disease Therapy by Gasparini, Fabrizio, Gomez-Mancilla, Baltazar, Di Paolo, Thérèse

    Published in Parkinson's disease (01-01-2013)
    “…Excessive glutamatergic signalling within the basal ganglia is implicated in the progression of Parkinson’s disease (PD) and inthe emergence of dyskinesia…”
    Get full text
    Journal Article
  19. 19

    Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys by Morissette, Marc, Bourque, Mélanie, Tremblay, Marie-Ève, Di Paolo, Thérèse

    Published in Cells (Basel, Switzerland) (16-02-2022)
    “…Proinflammatory markers were found in brains of Parkinson's disease (PD) patients. After years of L-Dopa symptomatic treatment, most PD patients develop…”
    Get full text
    Journal Article
  20. 20

    Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways by Bourque, Mélanie, Liu, Bin, Dluzen, Dean E, Di Paolo, Thérèse

    Published in Psychoneuroendocrinology (01-08-2011)
    “…Summary Male mice were reported to display greater methamphetamine-induced neurotoxicity than females. The present study evaluated the involvement of…”
    Get full text
    Journal Article